(Q48961319)

17 February 2018

title

Imaging of central nervous system lymphomas with iodine-123 labeled rituximab (English)

1 reference

17 February 2018

author name string

Markus Dietlein

1

1 reference

17 February 2018

Hendrik Pels

2

1 reference

17 February 2018

Holger Schulz

3

1 reference

17 February 2018

Oliver Staak

4

1 reference

17 February 2018

Peter Borchmann

5

1 reference

17 February 2018

Klaus Schomäcker

6

1 reference

17 February 2018

Thomas Fischer

7

1 reference

17 February 2018

Wolfgang Eschner

8

1 reference

17 February 2018

Elke Pogge von Strandmann

9

1 reference

17 February 2018

Harald Schicha

10

1 reference

17 February 2018

Andreas Engert

11

1 reference

17 February 2018

Roland Schnell

12

1 reference

17 February 2018

publication date

1 April 2005

1 reference

17 February 2018

European Journal of Haematology

published in

1 reference

17 February 2018

volume

74

1 reference

17 February 2018

issue

4

1 reference

17 February 2018

page(s)

348-352

1 reference

17 February 2018

Radiotherapy in the treatment of primary central nervous system lymphoma (PCNSL).

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00401.X

Primary Central Nervous System Lymphoma: Results of a Pilot and Phase II Study of Systemic and Intraventricular Chemotherapy With Deferred Radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00401.X

Primary CNS lymphoma: clinical presentation, pathological classification, molecular pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00401.X

Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00401.X

Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00401.X

Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00401.X

Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2004.00401.X

10.1111/J.1600-0609.2004.00401.X

21 January 2018

Identifiers

DOI

1 reference

17 February 2018

1 reference

17 February 2018